miR-539 inhibits human colorectal cancer progression by targeting RUNX2.

Wen D, Li S, Jiang W, Zhu J, Liu J, Zhao S

DOI: 10.1016/j.biopha.2017.09.044
Published: 2017 Nov
Container: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2017.09.044,
  title = {miR-539 inhibits human colorectal cancer progression by targeting RUNX2.},
  author = {Wen D and Li S and Jiang W and Zhu J and Liu J and Zhao S},
  year = {2017},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2017.09.044},
  url = {https://doi.org/10.1016/j.biopha.2017.09.044}
}

RIS

TY  - JOUR
TI  - miR-539 inhibits human colorectal cancer progression by targeting RUNX2.
AU  - Wen D
AU  - Li S
AU  - Jiang W
AU  - Zhu J
AU  - Liu J
AU  - Zhao S
PY  - 2017
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2017.09.044
UR  - https://doi.org/10.1016/j.biopha.2017.09.044
ER  -

APA

D, W., S, L., W, J., J, Z., J, L., & S, Z. (2017). miR-539 inhibits human colorectal cancer progression by targeting RUNX2.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2017.09.044

Source records

pubmed · retrieved 2026-09-25T13:07:03.543Z